May 21, 2019
With the advancement of programmatic media in the pharmaceutical space, many types of targeting are available that can identify and serve pharma ads to the right audiences, both in direct-to-consumer (DTC) and healthcare provider (HCP) advertising. When putting together a media plan for a specific brand, it is important to consider the disease state sensitivity associated with the brand before aligning on targeting tactics.
PulsePoint collaborated with Intouch Media to produce this POV that focuses on the nuances of personalized advertising and considerations for sensitive disease states, inclusive of messaging intended for patient and HCP audiences in the digital space; governing bodies and codes of conduct for media targeting; determining whether a disease is sensitive or not; and choosing the best, most compliant methods for targeting. Read the entire POV here.